{"entity":{"type":"insider","cik":"0001337798","url":"/insider/0001337798","json_url":"/insider/0001337798.json","name":"Cole G Bradley","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":171,"n_filings":113,"first":"2008-02-21","last":"2026-07-31","span_basis":"filed_date"},"name_variants":[{"name":"Cole G Bradley","source":"filing","n_filings":113,"first_seen":"2008-02-21","last_seen":"2026-07-31"}],"transactions":[{"id":6008268,"accession":"0001337798-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001337798-26-000004","line_url":"/filing/0001337798-26-000004#line-2","is_derivative":false,"issuer_cik":"0001337798","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001337798","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3673.0,"shares_display":"3,673","price_per_share":81.43,"price_display":"81.43","price_state":"stated","total_value":299092.39,"total_display":"299,092.39","total_whole":"299,092","shares_owned_after":11672.0,"shares_owned_after_display":"11,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-29","filed_date":"2026-07-31","scope":"insider"},{"id":6075626,"accession":"0001447362-26-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001447362-26-000008","line_url":"/filing/0001447362-26-000008","is_derivative":false,"issuer_cik":"0001337798","issuer_name":"CASTLE BIOSCIENCES INC","issuer_ticker":"CSTL","issuer_name_source":null,"issuer_url":"/issuer/0001337798","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7403.0,"shares_display":"7,403","price_per_share":28.465104687288935,"price_display":"28.47","price_state":"stated","total_value":210727.17,"total_display":"210,727.17","total_whole":"210,727","shares_owned_after":21964.0,"shares_owned_after_display":"21,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-09","scope":"insider","n_lines":2},{"id":2625897,"accession":"0001209191-20-011595","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-011595","line_url":"/filing/0001209191-20-011595#line-3","is_derivative":false,"issuer_cik":"0001124140","issuer_name":"EXACT SCIENCES CORP","issuer_ticker":"EXAS","issuer_name_source":null,"issuer_url":"/issuer/0001124140","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (General Manager - Diagnostics)","role_mark":"O","role_mark_label":"Officer (General Manager - Diagnostics)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Manager - Diagnostics","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27356.0,"shares_display":"27,356","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":2735600.0,"total_display":"2,735,600.00","total_whole":"2,735,600","shares_owned_after":10194.0,"shares_owned_after_display":"10,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-21","scope":"insider"},{"id":2652270,"accession":"0001209191-20-004038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-004038","line_url":"/filing/0001209191-20-004038#line-1","is_derivative":false,"issuer_cik":"0001124140","issuer_name":"EXACT SCIENCES CORP","issuer_ticker":"EXAS","issuer_name_source":null,"issuer_url":"/issuer/0001124140","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (General Manager - Diagnostics)","role_mark":"O","role_mark_label":"Officer (General Manager - Diagnostics)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Manager - Diagnostics","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":90.3,"price_display":"90.30","price_state":"stated","total_value":903000.0,"total_display":"903,000.00","total_whole":"903,000","shares_owned_after":8653.0,"shares_owned_after_display":"8,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-16","filed_date":"2020-01-17","scope":"insider"},{"id":7842703,"accession":"0001209191-19-057962","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-057962","line_url":"/filing/0001209191-19-057962#line-1","is_derivative":false,"issuer_cik":"0001124140","issuer_name":"EXACT SCIENCES CORP","issuer_ticker":"EXAS","issuer_name_source":null,"issuer_url":"/issuer/0001124140","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (General Manager - Diagnostics)","role_mark":"O","role_mark_label":"Officer (General Manager - Diagnostics)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Manager - Diagnostics","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28016.0,"shares_display":"28,016","price_per_share":80.38,"price_display":"80.38","price_state":"stated","total_value":2251926.08,"total_display":"2,251,926.08","total_whole":"2,251,926","shares_owned_after":30987.0,"shares_owned_after_display":"30,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-21","filed_date":"2019-11-25","scope":"insider"},{"id":7842234,"accession":"0001209191-19-052834","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-052834","line_url":"/filing/0001209191-19-052834#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22560.0,"shares_display":"22,560","price_per_share":69.0109,"price_display":"69.01","price_state":"stated","total_value":1556885.904,"total_display":"1,556,885.90","total_whole":"1,556,886","shares_owned_after":38970.0,"shares_owned_after_display":"38,970","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-07","filed_date":"2019-10-09","scope":"insider"},{"id":8677203,"accession":"0001209191-19-049152","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-049152","line_url":"/filing/0001209191-19-049152","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18112.0,"shares_display":"18,112","price_per_share":71.79089665415195,"price_display":"71.79","price_state":"stated","total_value":1300276.7202,"total_display":"1,300,276.72","total_whole":"1,300,277","shares_owned_after":43779.0,"shares_owned_after_display":"43,779","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-11","scope":"insider","n_lines":2},{"id":8677195,"accession":"0001209191-19-049152","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-049152","line_url":"/filing/0001209191-19-049152","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":72.522848212,"price_display":"72.52","price_state":"stated","total_value":1813071.2053,"total_display":"1,813,071.21","total_whole":"1,813,071","shares_owned_after":46439.0,"shares_owned_after_display":"46,439","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-11","scope":"insider","n_lines":3},{"id":8240241,"accession":"0001209191-19-045900","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-045900","line_url":"/filing/0001209191-19-045900","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":73.30980791666667,"price_display":"73.31","price_state":"stated","total_value":4398588.475,"total_display":"4,398,588.48","total_whole":"4,398,588","shares_owned_after":40195.0,"shares_owned_after_display":"40,195","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-14","scope":"insider","n_lines":2},{"id":8101539,"accession":"0001209191-19-041862","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-041862","line_url":"/filing/0001209191-19-041862","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6471.0,"shares_display":"6,471","price_per_share":57.08326666666667,"price_display":"57.08","price_state":"stated","total_value":369385.8186,"total_display":"369,385.82","total_whole":"369,386","shares_owned_after":43970.0,"shares_owned_after_display":"43,970","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-09","filed_date":"2019-07-11","scope":"insider","n_lines":2},{"id":8618703,"accession":"0001209191-19-036949","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-036949","line_url":"/filing/0001209191-19-036949","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":51.456284,"price_display":"51.46","price_state":"stated","total_value":257281.42,"total_display":"257,281.42","total_whole":"257,281","shares_owned_after":44492.0,"shares_owned_after_display":"44,492","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-11","filed_date":"2019-06-13","scope":"insider","n_lines":2},{"id":8616640,"accession":"0001209191-19-030060","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-030060","line_url":"/filing/0001209191-19-030060","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11424.0,"shares_display":"11,424","price_per_share":57.173688672969185,"price_display":"57.17","price_state":"stated","total_value":653152.2194,"total_display":"653,152.22","total_whole":"653,152","shares_owned_after":43722.0,"shares_owned_after_display":"43,722","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-15","scope":"insider","n_lines":4},{"id":8486830,"accession":"0001209191-19-024397","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-024397","line_url":"/filing/0001209191-19-024397","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":67.60803152,"price_display":"67.61","price_state":"stated","total_value":1014120.4728,"total_display":"1,014,120.47","total_whole":"1,014,120","shares_owned_after":44022.0,"shares_owned_after_display":"44,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-11","scope":"insider","n_lines":4},{"id":8065063,"accession":"0001209191-19-019399","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-019399","line_url":"/filing/0001209191-19-019399","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":75.15151933333334,"price_display":"75.15","price_state":"stated","total_value":1127272.79,"total_display":"1,127,272.79","total_whole":"1,127,273","shares_owned_after":45822.0,"shares_owned_after_display":"45,822","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider","n_lines":4},{"id":7945450,"accession":"0001209191-19-010352","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-010352","line_url":"/filing/0001209191-19-010352","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":80.86824176666667,"price_display":"80.87","price_state":"stated","total_value":1213023.6265,"total_display":"1,213,023.63","total_whole":"1,213,024","shares_owned_after":52132.0,"shares_owned_after_display":"52,132","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-14","scope":"insider","n_lines":3},{"id":7976402,"accession":"0001209191-19-003164","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-19-003164","line_url":"/filing/0001209191-19-003164","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":67.02672504,"price_display":"67.03","price_state":"stated","total_value":1005400.8756,"total_display":"1,005,400.88","total_whole":"1,005,401","shares_owned_after":44047.0,"shares_owned_after_display":"44,047","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-08","filed_date":"2019-01-09","scope":"insider","n_lines":6},{"id":6914326,"accession":"0001209191-18-062513","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-18-062513","line_url":"/filing/0001209191-18-062513","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":71.94791706,"price_display":"71.95","price_state":"stated","total_value":1079218.7559,"total_display":"1,079,218.76","total_whole":"1,079,219","shares_owned_after":51947.0,"shares_owned_after_display":"51,947","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-13","scope":"insider","n_lines":9},{"id":6913965,"accession":"0001209191-18-058707","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-18-058707","line_url":"/filing/0001209191-18-058707#line-10","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2817.0,"shares_display":"2,817","price_per_share":78.2871,"price_display":"78.29","price_state":"stated","total_value":220534.7607,"total_display":"220,534.76","total_whole":"220,535","shares_owned_after":51131.0,"shares_owned_after_display":"51,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-13","filed_date":"2018-11-15","scope":"insider"},{"id":6913961,"accession":"0001209191-18-058707","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-18-058707","line_url":"/filing/0001209191-18-058707#line-9","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001337798","owner_name":"Cole G Bradley","owner_display_name":"Cole G Bradley","owner_url":"/insider/0001337798","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1976.0,"shares_display":"1,976","price_per_share":78.3428,"price_display":"78.34","price_state":"stated","total_value":154805.3728,"total_display":"154,805.37","total_whole":"154,805","shares_owned_after":46972.0,"shares_owned_after_display":"46,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-13","filed_date":"2018-11-15","scope":"insider"}],"collapsed":true,"next_cursor":"2018-11-13|6913961","ledger_fault":false,"count":{"value":171,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":171,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":171},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals International, plc","url":"/issuer/0001730430","role":"Director","n_filings":1,"first_seen":"2026-07-31","last_seen":"2026-07-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001447362","name":"CASTLE BIOSCIENCES INC","url":"/issuer/0001447362","role":"Director","n_filings":1,"first_seen":"2026-03-09","last_seen":"2026-03-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001124140","name":"EXACT SCIENCES CORP","url":"/issuer/0001124140","role":"Officer (General Manager - Diagnostics)","n_filings":3,"first_seen":"2019-11-25","last_seen":"2020-02-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001131324","name":"GENOMIC HEALTH INC","url":"/issuer/0001131324","role":"Officer (CFO)","n_filings":108,"first_seen":"2008-02-21","last_seen":"2019-10-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001337798","retrieved_at":"2026-08-22T16:07:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}